![Robert Oliver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Oliver
Direktor/Vorstandsmitglied bei
PSYBIO THERAPEUTICS CORP.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Robert L.
Oliver is currently an Independent Director at Exelixis, Inc. since 2023.
Mr. Oliver is a Director at Neurotez, Inc., PsyBio Therapeutics Corp.
since 2021, and Hyalo Technologies LLC.
Mr. Oliver is a Member of the Governors Board at the Accreditation Council for Medical Affairs.
Formerly, Mr. Oliver was President & Chief Executive Officer at Otsuka America Pharmaceutical, Inc. and Otsuka Holdings Co., Ltd. from 2016 to 2017.
Mr. Oliver was Chief Executive Officer at V ClinBio LLC and Chairman at Otsuka Canada Pharmaceutical, Inc. Mr. Oliver served as Independent Director at Immunomedics, Inc. in 2017 and at Allarity Therapeutics, Inc. in 2023.
Mr. Oliver was Vice President & Global Business Manager-Oncology at Wyeth Pharmaceuticals LLC.
Mr. Oliver completed undergraduate studies at Rutgers State University of New Jersey and earned an MBA from Erivan K.
Haub School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EXELIXIS, INC. 0,01 % | 27.05.2026 | 29 487 ( 0,01 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Robert Oliver
| Unternehmen | Position | Beginn |
|---|---|---|
| PSYBIO THERAPEUTICS CORP. | Direktor/Vorstandsmitglied | 21.04.2021 |
| EXELIXIS, INC. | Direktor/Vorstandsmitglied | 31.05.2023 |
Neurotez, Inc.
 Neurotez, Inc. BiotechnologyHealth Technology Develops leptin product as a novel hormone replacement therapy for alzheimer’s diseases | Direktor/Vorstandsmitglied | - |
Hyalo Technologies LLC
 Hyalo Technologies LLC BiotechnologyHealth Technology Operates as a biotech and pharmaceuticals company that provides nanotechnology drug delivery system services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Oliver
| Unternehmen | Position | Ende |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.08.2023 |
| IMMUNOMEDICS, INC. | Direktor/Vorstandsmitglied | 16.02.2017 |
| OTSUKA HOLDINGS CO., LTD. | Vorstandsvorsitzender | 01.01.2017 |
V ClinBio LLC
 V ClinBio LLC BiotechnologyHealth Technology Provides biotechnology services | Vorstandsvorsitzender | - |
Otsuka Canada Pharmaceutical, Inc.
 Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Vorsitzender | - |
Ausbildung von Robert Oliver
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Otsuka Holdings Co., Ltd.
 Otsuka Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in pharmaceutical preparations | Health Technology |
Neurotez, Inc.
Neurotez, Inc. BiotechnologyHealth Technology Develops leptin product as a novel hormone replacement therapy for alzheimer’s diseases | Health Technology |
Erivan K. Haub School of Business
 Erivan K. Haub School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
V ClinBio LLC
V ClinBio LLC BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
PsyBio Therapeutics Corp.
 PsyBio Therapeutics Corp. Pharmaceuticals: OtherHealth Technology Develops biosynthetic psychoactive compounds | Health Technology |
Allarity Therapeutics, Inc.
 Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Hyalo Technologies LLC
Hyalo Technologies LLC BiotechnologyHealth Technology Operates as a biotech and pharmaceuticals company that provides nanotechnology drug delivery system services | Health Technology |
